spacer
home > ebr > Autumn 2006
PUBLICATIONS

European Biopharmaceutical Review

ebr
Autumn 2006
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EBR provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of of biopharmaceuticals, take a look below at the range of articles featured in this issue of EBR
   
Text
PDF
Dr Helen Tayton-Martin, Editor of EBR, introduces the penultimate issue of the year  
download pdf
bullet
BioFinance and Management
Market differentiation and localisation are crucial to successful product launches and thereby the survival of biotech companies; Gary Muddyman of Conversis explains why All that is GILTed is Gold  
download pdf
In Taking Stock of the Future, Ian Rice at Corporate Synergy Plc outlines the major issues to be addressed by a company considering flotation as a route to fund expansion, such as the appointment of advisers, documentation, fundraising and marketing  
download pdf
In Low Country Loot: Biotech Investment in the Benelux, Yvette Verleisdonk and Jacques Meunier at NautaDutilh provide a round-up of the latest investment trends in Belgium, the Netherlands and Luxembourg, where rules to promote an investor-friendly environment have been put in place  
download pdf
Taking Scotland as an example, Alan Muir at Seven Hills Venture Partners Ltd looks at the mutual benefits of international collaboration and reports on European attitudes towards partnerships on this level, in Biotech without Borders  
download pdf
In Spin-outs: Weaving the Threads of Success, Tom Hockaday at Isis Innovation Ltd evaluates the challenges and rewards of commercialising university technology, from installing a cohesive team of adaptable, proactive individuals to devise a business plan, to realising value  
download pdf
bullet
BioBusiness Development
European industry has long needed unified regulations to determine the freedom available to companies producing versions of innovative drugs. In Generalising Generics, Torben Ravn Rasmussen at the Internationalt Patent-Bureau A/S explores the effectiveness of the nascent Bolar Provisions  
download pdf
Named patient supply can facilitate swift access to treatment for individuals with serious conditions, in addition to providing valuable early experience of new medicines amongst healthcare professionals. In The Name Game, Natalie Douglas at IDIS looks at European regulations surrounding this practice  
download pdf
Diane J Romza-Kutz and Karen A Weaver of Epstein Becker & Green PC adopt A Practical State of Mind in their article on the teething troubles of the European Clinical Trials Directive  
download pdf
Are you REACHing Readiness? Hanna Paloheimo at Borenius and Kemppinen anticipates the 2007 enactment of the new regulations governing registration, evaluation and authorisation of chemicals  
download pdf
Dr Christof Gänzler of Spotfire explains how to avoid a quagmire of unqualified information by using visual analytics to extricate meaning and value from data, in Picture This  
download pdf
bullet
BioResearch and Innovation
Dr Deepak Singh at Accelrys uncovers the conundrums and complexities of Nanodesign: Triumph in Tiny Proportions  
download pdf
The vast majority of cancer deaths worldwide are attributable to metastasis, and yet most treatments focus on the destruction of primary tumours. Professor Robert Kiss at Unibioscreen looks at the potential of current investigations into halting this mechanism, in Therapeutic Agents to Challenge Cancer Metastasis  
download pdf
Dr Alison Kerr and Dr Gordon Meiklejohn at MD Biosciences give an overview of current models and recent technological advances such as adoptive transfer, in Asthma: Measuring the Breadth of New Medicines  
download pdf
Variability is a significant problem in the reproduction of embryonic stem cells; in The Self-Renewing Solution, Solène Jamet and Patrick J Mee of Stem Cell Sciences plc survey progress towards an easier-to-use system producing uniform cells  
download pdf
bullet
Discovery Technology
Natural product-based research lost favour in the 1990s, due in part to the perception of combinatorial chemistry as a panacea for the drug discovery process. In Natural Selection, Phil Dudfield and Fritz Hansske at BioFocus DPI explore the revival of this approach  
download pdf
A new discovery technique welcomed by pharma and biotech alike goes under the spotlight in A Cohesive View of Fragments, by Mark Whittaker, Thomas Hesterkamp and John Barker at Evotec  
download pdf
bullet
BioDevelopment and Regulatory
Miroslav Reljanovic of Ergomed assesses some of the most promising management solutions - such as co-development deals - for efficiency and cost-saving in clinical trials, in A New Paradigm in Clinical Co-Development  
download pdf
In Generation X, Dr Adam Walker of Bioniqs Ltd outlines the development of ionic liquids - a burgeoning technology finding uses in natural product extraction, reactor cleaning and bio-catalysis  
download pdf
Adele Long at the BioMed Healthcare Technology Cooperative discusses recent collaborations aimed at improving treatments for an indication all too often relegated to 'Cinderella' status, in Healthcare Technology Cooperatives: Delivering Progress For Urinary Incontinence  
download pdf
bullet
BioFormulation and Manufacturing
Downstream purification carries the highest cost burden within the manufacturing process. Ligands are likely to play an increasing role in improving efficiency as efforts to create more stable, selective versions continue, says Phaedria M St Hilaire at VersaMatrix, in To Affinity and Beyond  
download pdf
As in so many areas of the industry, scrutiny is set to reach new levels in the field of process development, installing the concept of Quality by Design and changing industry practices and relationships. Bo Kara at Avecia Biotechnology charts the changes  
download pdf
In Bacterial Systems Breed New Expectation, Dr Søren M Madsen and Sean A MacDonald at Bioneer A/S urge the ongoing evolution of production solutions in order to meet the challenges of rising demand and variety  
download pdf
bullet
Preview
In EuroBiO: Meeting Europe's Potential in the Life Sciences, Axel Khan, EuroBiO President, explains the ethos behind the event, while Eric Poincelet, Commissioner General, gives a rundown of its highlights  
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July and October

News and Press Releases

Klöckner Pentaplast to introduce latest shrink label technologies and delivery master class at Labelexpo Americas 2016


More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

Industry Events

BioPharm America™ 2017—10th Annual International Partnering Conference

26-27 September 2017, 39 Dalton Street, Boston, MA 02116

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement